An image of Eppendorf's biobased consumables

CREDIT: Eppendorf

Eppi made from 100% cooking oil?

Eppendorf Safe-Lock Tubes BioBased are made from 100 percent renewable biobased feedstock of second generation
| 1 min read
Written byEppendorf
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Hamburg, May 2025 - The new generation of Safe-Lock Tubes is finally also biobased. "Eppendorf Safe-Lock Tubes BioBased" are made from 100 percent renewable biobased feedstock of second generation (recycled e.g. from food oil wastes and residues; based on Mass-Balance-Approach). Thus, these tubes in the sizes 0.5 mL, 1.5 mL and 2.0 mL, better known in the laboratory world as “Eppi®”, are made of certified polypropylene based on renewable, used raw materials and are called same as Eppendorf Tubes® BioBased, epT.I.P.S.® BioBased and twin.tec® Trace PCR Plates BioBased, with a “BioBased” in the product name.

Again, Eppendorf shows, that they are no longer focusing only on the development of new products, but also on new manufacturing materials. In line with the "Reduce, Reuse, Recycle" concept, the main goal is to produce polymer products in a much more sustainable way without compromising the guaranteed product quality and performance needed in increasingly demanding research.

The Consumable production center in Oldenburg/Germany meets the requirements of the ISCC PLUS (International Sustainability & Carbon Certification) certification system. Additionally, sustainability of the tubes is certified by “My Green Lab®” with the “ACT Label” (Accountability, Consistency, Transparency).

www.eppendorf.com/BioBased

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Spatial Proteomics
Find out how advanced tissue imaging approaches are enabling researchers to connect complex biological data with clinically meaningful outcomes.
A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Modeling neurotropic viral infections using human cerebral organoids
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue